Testicular Cancer - Results from #320

Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global Analysis. July 25, 2022

A Machine Learning Algorithm for Predicting the Risk of Developing to M1b Stage of Patients With Germ Cell Testicular Cancer. July 21, 2022

Associations of Body Fat Distribution and Cardiometabolic Risk of Testicular Cancer Survivors After Cisplatin-Based Chemotherapy. July 20, 2022

Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases. July 15, 2022

Pathologic Findings and Clinical Outcomes in Patients who Required Neoadjuvant Chemotherapy Prior to Orchiectomy for Testicular Germ Cell Tumors. July 13, 2022

Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study. July 8, 2022

The impact of testicular cancer and its treatment on masculinity: A systematic review. July 7, 2022

Management of Testicular Germ Cell Tumor With Somatic-Type Malignancy. July 6, 2022

A Role of the TEX101 Interactome in the Common Aetiology Behind Male Subfertility and Testicular Germ Cell Tumor. July 5, 2022

Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer. June 30, 2022

A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors. June 29, 2022

Metastatic testicular cancer presenting with hematuria and flank pain. June 27, 2022

A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention). June 20, 2022

Sperm-specific proteins: new implications for diagnostic development and cancer immunotherapy. June 20, 2022

Association study between polymorphisms in DNA methylation-related genes and testicular germ cell tumor risk. June 16, 2022

ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update. June 15, 2022

Process Evaluation of a Sport-Based Supportive Care Intervention for Testicular Cancer Survivors: A Mixed Methods Study. June 13, 2022

Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor. June 9, 2022

Guideline discordant care in patients with metastatic germ cell tumors. June 8, 2022

Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors. June 3, 2022

Page 17 of 94